PAP or Pill?
Those humble antidepressants have their own advantages, of course. For one thing, they’re likely to be cheaper, more readily available.
Category: Treatment
Addiction clinicians ROCK! It’s a complex field and evolving all the time. But some tried-and-true tools will never go out of date. Strategies, tips, and even a laugh or two.
Treatment
Latest
One for PTSD, One for Pain
Many of the chronic pain patients I’ve run into suffer from both depression and anxiety, much of it related to their experience of pain.
Read More
Change, at Ground Level
…real progress has been made — especially with the most challenging population, the very chronic, relapsing, “street” drug user.
Read More
A Visit to Injection Central
Target client for these operations is the chronic daily user, mostly but not exclusively of opioids, and that’s a difficult population for such programs to work with.
Read More
The Best Laid Plans…
A user could count on a better exchange rate for the Safer Supply medication, whether in cash or illicit heroin, fentanyl, whatever.
Read More
“It was never a problem”
That’s important in a treatment context, because a history of multiple drug use means they will be tempted to focus on one substance — their “drug of choice”, whatever they may feel that is — while minimizing the importance of the others.
Read More
Antidepressants under fire?
“Kennedy has long expressed skepticism about antidepressants, especially (SSRIs), questioning their safety and suggesting they are as addictive as heroin.”
Read More
Meds for Drinking Problems?
…the main challenge for all these meds is “medication adherence.” Translation: patients stop taking them.
Read More
Limits of Harm Reduction
We either do what works, as challenging as that may be, or we accept the consequences of failure.
Read More
Seven Trips to Rehab pt 2
I remember the late James Milam PhD suggesting that the ability to vividly recall one’s first use of a substance might actually be an indicator of future problems.
Read More
7 Trips to Rehab, Part One
These are issues that users seldom take into consideration, in the rush to get the drug. But healthcare professionals, and their attorneys, have to consider them.
Read More
At last a treatment for meth?
I’m curious as to whether the reductions in meth use could be expected to lead to eventual abstinence where meth was concerned. That’s been the hope for other maintenance treatments, for the most part unrealized.
Read More
The FDA & MDMA
…we still haven’t made much progress in terms of agreeing on what qualifies as legitimate psychotherapy. Or perhaps more importantly, what doesn’t.
Read More